Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss
Спатник всё
15 views
Skip to first unread message
⁹⁹⁹√
May 19, 2021, 11:30:21 AM5/19/21
to
Doubts Mount About Efficacy of Russia's Sputnik Vaccine
https://www.voanews.com/europe/doubts-mount-about-efficacy-russias-sputnik-vaccine
Doubts are mounting about the efficacy of Russia’s Sputnik vaccine. Drug
regulators in the Czech Republic and Brazil have withheld approval and
counterparts in Slovakia have also expressed doubts.
European Union regulators are still assessing Sputnik for its
effectiveness and safety but a former executive director of the European
Medicines Agency, EMA, told the Politico.eu news site that objections
raised about Sputnik by Brazil’s regulatory authority, Anvisa, would
likely be taken seriously by their counterparts in Brussels.
“It's a very mature authority,” said Rasi, who added that its flagging
of quality and safety issues are worrisome. Anvisa announced on April 28
that it was withholding approval because of “flaws in product
development” which deviate from the quality standards recommended by the
World Health Organization (WHO).
The authority also noted “an absence or insufficiency of quality
control, safety and efficacy data.” It raised concerns also with the
vaccine’s efficacy for people “with low immunity and respiratory
problems, among other health problems.” The Slovak medicines authority
has also expressed worries about quality control and insufficient data.
Irena Storová, head of SÚKL, told Slovakia’s Radiožurnál recently that
the regulator received “only a fraction of the documentation that is
submitted by default for the registration or assessment of a drug or
medicine.”
https://www.voanews.com/europe/doubts-mount-about-efficacy-russias-sputnik-vaccine
Doubts are mounting about the efficacy of Russia’s Sputnik vaccine. Drug
regulators in the Czech Republic and Brazil have withheld approval and
counterparts in Slovakia have also expressed doubts.
European Union regulators are still assessing Sputnik for its
effectiveness and safety but a former executive director of the European
Medicines Agency, EMA, told the Politico.eu news site that objections
raised about Sputnik by Brazil’s regulatory authority, Anvisa, would
likely be taken seriously by their counterparts in Brussels.
“It's a very mature authority,” said Rasi, who added that its flagging
of quality and safety issues are worrisome. Anvisa announced on April 28
that it was withholding approval because of “flaws in product
development” which deviate from the quality standards recommended by the
World Health Organization (WHO).
The authority also noted “an absence or insufficiency of quality
control, safety and efficacy data.” It raised concerns also with the
vaccine’s efficacy for people “with low immunity and respiratory
problems, among other health problems.” The Slovak medicines authority
has also expressed worries about quality control and insufficient data.
Irena Storová, head of SÚKL, told Slovakia’s Radiožurnál recently that
the regulator received “only a fraction of the documentation that is
submitted by default for the registration or assessment of a drug or
medicine.”
⁹⁹⁹√
May 19, 2021, 11:51:05 AM5/19/21
to
by the Russians and not by an authoritative international regulator.
Funded by the state and developed by the Gamaleya Research Institute in
Moscow, the rapid Russian approval last year in August of the vaccine,
which was named for the satellite from half a century ago, was met with
skepticism in the broader international scientific community.
Experts expressed their disapproval of Russian authorities for approving
distribution before the completion of trials, suggesting the rapidity of
authorization was done so as to be able to tout Russian scientific
prowess.
⁹⁹⁹√
May 19, 2021, 11:52:44 AM5/19/21
to
On 5/19/2021 11:51 AM, ⁹⁹⁹√ wrote:
> Experts expressed their disapproval of Russian authorities for approving
> distribution before the completion of trials, suggesting the rapidity of
> authorization was done so as to be able to tout Russian scientific prowess.
кстати, Хантер, помнишь, я тебе говорил, что в журналах всякое, бывает,
> Experts expressed their disapproval of Russian authorities for approving
> distribution before the completion of trials, suggesting the rapidity of
> authorization was done so as to be able to tout Russian scientific prowess.
печатают
так вот
But scientific doubts about Sputnik remerged last week when The Lancet
published a paper by a team of scientists drawn from Europe, the U.S.
and Russia questioning the 2020 study of the vaccine the medical journal
published and flagging significant discrepancies in the data from the
phase two and three trials conducted by the Gamaleya Research Institute,
the vaccine’s developer.
“Restricted access to data hampers trust in research,” the scientists
said in last week’s study. “Access to data underpinning study findings
is imperative to check and confirm the findings claimed. It is even more
serious if there are apparent errors and numerical inconsistencies in
the statistics and results presented,” they said. The team included
Enrico Bucci of Temple University in the U.S., Gowri Gopalakrishna from
Amsterdam University and Raffaele Calogero from the University of Turin.
In reply, scientists from the Gamaleya Research Institute say data
discrepancies occurred because of typing errors and they point to the
approval of Sputnik by 51 countries showing they have been “fully
transparent and comply with all regulatory requirements.”
⁹⁹⁹√
May 19, 2021, 11:53:37 AM5/19/21
to
On 5/19/2021 11:51 AM, ⁹⁹⁹√ wrote:
> Experts expressed their disapproval of Russian authorities for
> approving distribution before the completion of trials, suggesting the
> rapidity of authorization was done so as to be able to tout Russian
> scientific prowess.
ещё понравилось:
> Experts expressed their disapproval of Russian authorities for
> approving distribution before the completion of trials, suggesting the
> rapidity of authorization was done so as to be able to tout Russian
> scientific prowess.
Russian President Vladimir Putin on Thursday during a video conference
praised Russia's vaccine, saying it as “reliable as a Kalashnikov
assault rifle.”
⁹⁹⁹√
May 19, 2021, 11:54:14 AM5/19/21
to
Sputnik isn’t the only non-Western vaccine prompting reservations.
Despite approval by WHO of China’s Sinopharm, some scientific
researchers have expressed worries about the lack of data on that
vaccine’s efficacy, too, and likewise with Sinovac, another Chinese vaccine.
According to researchers outside China, Sinovac’s efficacy rate is
around 50%, and Sinopharm’s 79%, much lower than that of the rates for
U.S.-developed vaccines like Moderna and Pfizer, both of which are above
90%.
⁹⁹⁹√
May 19, 2021, 12:01:12 PM5/19/21
to
On 5/19/2021 11:53 AM, ⁹⁹⁹√ wrote:
(который недавно похоронил маму и чуть не потерял отца, оба от ковида)
комментарий кого-то из питера:
"Мы всей семьей переболели после двух прививок, абсолютно лайтовый
вариант - из симптомов только кашель у мамы (0% поражения), потеря
обоняния у меня и температура 37.1 у мужа."
при эффективности 95% вероятность такого сценария - 0.01%
Sericinus hunter
May 19, 2021, 12:18:15 PM5/19/21
to
On 5/19/2021 11:52 AM, ⁹⁹⁹√ wrote:
> On 5/19/2021 11:51 AM, ⁹⁹⁹√ wrote:
>> Experts expressed their disapproval of Russian authorities for approving distribution before the completion of trials, suggesting the rapidity of authorization was done so as to be able to tout Russian scientific prowess.
>
> кстати, Хантер, помнишь, я тебе говорил, что в журналах всякое, бывает, печатают
Помню.
> On 5/19/2021 11:51 AM, ⁹⁹⁹√ wrote:
>> Experts expressed their disapproval of Russian authorities for approving distribution before the completion of trials, suggesting the rapidity of authorization was done so as to be able to tout Russian scientific prowess.
>
> кстати, Хантер, помнишь, я тебе говорил, что в журналах всякое, бывает, печатают
> так вот
Ну, хреново, что я могу сказать. Время идёт, всякие штуки будут вылезать у всех.
Но почему прямо вот "всё"?
⁹⁹⁹√
May 19, 2021, 12:19:50 PM5/19/21
to
D
May 19, 2021, 8:14:15 PM5/19/21
to
On 5/19/2021 11:54 AM, ⁹⁹⁹√ wrote:
>> ещё понравилось: >> Russian President Vladimir Putin on Thursday during a video conference
>> praised Russia's vaccine, saying it as “reliable as a Kalashnikov
>> assault rifle.”
>
> китайцы - тоже того
>
> Sputnik isn’t the only non-Western vaccine prompting reservations.
А в разработке Модерны участвовали афро-американские ученые?
>> ещё понравилось: >> Russian President Vladimir Putin on Thursday during a video conference
>> praised Russia's vaccine, saying it as “reliable as a Kalashnikov
>> assault rifle.”
>
> китайцы - тоже того
>
> Sputnik isn’t the only non-Western vaccine prompting reservations.
Тоже не годится ...
Bye, Anatol
Const
May 20, 2021, 12:36:47 AM5/20/21
to
???√ <99...@russian.z1> wrote:
> > Irena Storov?, head of S?KL, told Slovakia?s Radio?urn?l recently that
> > the regulator received ?only a fraction of the documentation that is
> Sputnik was the first coronavirus vaccine to be registered, albeit only
> by the Russians and not by an authoritative international regulator.
> Funded by the state and developed by the Gamaleya Research Institute in
> Moscow, the rapid Russian approval last year in August of the vaccine,
> which was named for the satellite from half a century ago, was met with
> skepticism in the broader international scientific community.
Это на самом деле вранье.
> Experts expressed their disapproval of Russian authorities for approving
> distribution before the completion of trials, suggesting the rapidity of
> authorization was done so as to be able to tout Russian scientific
> prowess.
Не без этого, конечно.
Но "экспертов" этих мы тоже видели.
---
Const
> > Irena Storov?, head of S?KL, told Slovakia?s Radio?urn?l recently that
> > the regulator received ?only a fraction of the documentation that is
> > submitted by default for the registration or assessment of a drug or
> > medicine.?
> Sputnik was the first coronavirus vaccine to be registered, albeit only
> by the Russians and not by an authoritative international regulator.
> Funded by the state and developed by the Gamaleya Research Institute in
> Moscow, the rapid Russian approval last year in August of the vaccine,
> which was named for the satellite from half a century ago, was met with
> skepticism in the broader international scientific community.
> Experts expressed their disapproval of Russian authorities for approving
> distribution before the completion of trials, suggesting the rapidity of
> authorization was done so as to be able to tout Russian scientific
> prowess.
Но "экспертов" этих мы тоже видели.
---
Const
DL
May 22, 2021, 8:31:50 AM5/22/21
to
0 new messages